Dave McDonald

Dave McDonald is the Head of Life Sciences Investment Banking at Lake Street Capital Markets, LLC, a position he has held since November 2014. In this role, he leads the firm's efforts to meet the funding and strategic advisory needs of small and microcap growth companies within the biopharma, diagnostics, and medtech sectors. His extensive experience in capital markets and investment banking positions him as a key figure in facilitating financial transactions and providing strategic insights to clients in the life sciences industry.123

Professional Background

Before joining Lake Street Capital Markets, McDonald served as the Chief Business Officer and President of SillaJen, Inc., where he was instrumental in developing corporate strategies and acquisition initiatives aimed at transforming the company into a leader in targeted oncolytic therapy. His previous roles also include significant positions at Delcath Systems, AngioDynamics, and RBC Capital Markets, where he focused on business development and healthcare investment banking.12

Education

McDonald holds a Bachelor of Arts in Economics from St. Olaf College, which he completed between 1978 and 1982.1

Current Roles

In addition to his role at Lake Street, McDonald is a board member of Nuwellis, Inc., contributing his expertise to the company's strategic direction.13 Throughout his career, he has raised approximately $6 billion in financing for various clients, showcasing his effectiveness in the investment banking sector.4